BACKGROUND: Parallel, thin (<100 microm) planes of synchrotron-generated X rays, have been shown to spare normal tissues and preferentially damage tumors in animal models. The aim of the present study was to assess the effect of such microbeams directed unidirectionally on angioplasted rat carotid arteries. METHODS AND MATERIALS: Three groups of Sprague-Dawley rats were studied: (a) rats with normal, untreated arteries, (b) rats treated by balloon angioplasty, but not irradiated, and (c) rats treated with balloon angioplasty and exposed to single fraction, unidirectional, parallel, microbeams an hour after angioplasty. The microbeam array, 15 mm widex7.6 mm high, consisting of 27-microm-wide beam slices, spaced 200 microm center-to-center laterally traversed the damaged artery. The in-depth in-beam dose was 150 Gy, the "valley" dose (dose midway between microbeams resulting mainly from X-ray scattering) was 4.5 Gy on average, and the "integrated" (averaged) dose was 26 Gy. RESULTS: Microbeam irradiation, as given in the present study, was tolerated, but was insufficient to significantly suppress the neointimal hyperplasia. DISCUSSION: The microbeam dose used is considered low. Dose escalation would be necessary to reach conclusive results regarding the X-ray microbeam efficacy to control restenosis.
BACKGROUND: Parallel, thin (<100 microm) planes of synchrotron-generated X rays, have been shown to spare normal tissues and preferentially damage tumors in animal models. The aim of the present study was to assess the effect of such microbeams directed unidirectionally on angioplasted rat carotid arteries. METHODS AND MATERIALS: Three groups of Sprague-Dawley rats were studied: (a) rats with normal, untreated arteries, (b) rats treated by balloon angioplasty, but not irradiated, and (c) rats treated with balloon angioplasty and exposed to single fraction, unidirectional, parallel, microbeams an hour after angioplasty. The microbeam array, 15 mm widex7.6 mm high, consisting of 27-microm-wide beam slices, spaced 200 microm center-to-center laterally traversed the damaged artery. The in-depth in-beam dose was 150 Gy, the "valley" dose (dose midway between microbeams resulting mainly from X-ray scattering) was 4.5 Gy on average, and the "integrated" (averaged) dose was 26 Gy. RESULTS: Microbeam irradiation, as given in the present study, was tolerated, but was insufficient to significantly suppress the neointimal hyperplasia. DISCUSSION: The microbeam dose used is considered low. Dose escalation would be necessary to reach conclusive results regarding the X-ray microbeam efficacy to control restenosis.
Authors: F A Dilmanian; Y Qu; S Liu; C D Cool; J Gilbert; J F Hainfeld; C A Kruse; J Laterra; D Lenihan; M M Nawrocky; G Pappas; C-I Sze; T Yuasa; N Zhong; Z Zhong; J W McDonald Journal: Nucl Instrum Methods Phys Res A Date: 2005-08-11 Impact factor: 1.455
Authors: Raphaël Serduc; Elke Bräuer-Krisch; Erik A Siegbahn; Audrey Bouchet; Benoit Pouyatos; Romain Carron; Nicolas Pannetier; Luc Renaud; Gilles Berruyer; Christian Nemoz; Thierry Brochard; Chantal Rémy; Emmanuel L Barbier; Alberto Bravin; Géraldine Le Duc; Antoine Depaulis; François Estève; Jean A Laissue Journal: PLoS One Date: 2010-02-03 Impact factor: 3.240
Authors: Raphaël Serduc; Audrey Bouchet; Benoît Pouyatos; Luc Renaud; Elke Bräuer-Krisch; Géraldine Le Duc; Jean A Laissue; Stefan Bartzsch; Nicolas Coquery; Yohan van de Looij Journal: PLoS One Date: 2014-02-05 Impact factor: 3.240
Authors: Elisabeth Schültke; Jacques Balosso; Thomas Breslin; Guido Cavaletti; Valentin Djonov; Francois Esteve; Michael Grotzer; Guido Hildebrandt; Alexander Valdman; Jean Laissue Journal: Br J Radiol Date: 2017-07-27 Impact factor: 3.039
Authors: Mohammad Johari Ibahim; Jeffrey C Crosbie; Yuqing Yang; Marina Zaitseva; Andrew W Stevenson; Peter A W Rogers; Premila Paiva Journal: PLoS One Date: 2014-06-19 Impact factor: 3.240